Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. | Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC)

Levin GP, Robinson-Cohen C, De Boer IH, Houston DK, Lohman K, Liu Y, Kritchevsky SB, Cauley JA, Tanaka T, Ferrucci L, Bandinelli S, Patel KV, Hagström E, Michaëlsson K, Melhus H, Wang T, Wolf M, Psaty BM, Siscovick D, Kestenbaum B. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA. 2012 Nov 14;308(308). 1898-905. PMID: 23150009 [PubMed] PMCID: PMC3645444 NIHMSID: NIHMS457084.

Abstract

Lower serum 25-hydroxyvitamin D concentrations are associated with greater risks of many chronic diseases across large, prospective community-based studies. Substrate 25-hydroxyvitamin D must be converted to 1,25-dihydroxyvitamin D for full biological activity, and complex metabolic pathways suggest that interindividual variability in vitamin D metabolism may alter the clinical consequences of measured serum 25-hydroxyvitamin D.